NME2 reduces proliferation, migration and invasion of gastric cancer cells to limit metastasis.

Abstract

Gastric cancer is one of the most common malignancies and has a high rate of metastasis. We hypothesize that NME2 (Nucleoside Diphosphate Kinase 2), which has previously been considered as an anti-metastatic gene, plays a role in the invasiveness of gastric cancer cells. Using a tissue chip technology and immunohistochemistry, we demonstrated that NME2 expression was associated with levels of differentiation of gastric cancer cells and their metastasis into the lymph nodes. When the NME2 gene product was over-expressed by ;in vitro stable transfection, cells from BGC823 and MKN45 gastric cancer cell lines had reduced rates of proliferation, migration, and invasion through the collagen matrix, suggesting an inhibitory activity of NME2 in the propagation and invasion of gastric cancer. NME2 could, therefore, severe as a risk marker for gastric cancer invasiveness and a potential new target for gene therapy to enhance or induce NME2 expression.

• Authors: Yan-fei Liu, Aijun Yang, Wei Liu, Chenyu Wang, Min Wang, Lihan Zhang, Dongcang Wang, Jing-fei Dong, Min Li
• Journal: PloS one (PLoS One) Vol. 10 Issue 2 Pg. e0115968 ( 2015) ISSN: 1932-6203 [Electronic] United States
• PMID: 25700270 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• NM23 Nucleoside Diphosphate Kinases
• NME2 protein, human

Topics

• Adenocarcinoma (enzymology, secondary)
• Cell Line, Tumor
• Cell Movement
• Cell Proliferation
• Female
• Humans
• Male
• Middle Aged
• NM23 Nucleoside Diphosphate Kinases (physiology)
• Neoplasm Invasiveness
• Stomach Neoplasms (enzymology, pathology)